Daniel H. White is CEO & President at Clearside Biomedical, Inc. (CLSD). They have made 3 open-market trades across 1 company since 2016, most recently 2018-06-04.
CIK 0001664697
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $100K since 2018, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLSD | 472,335 | $194K |
Shares reported on the most recent Form 4, priced at the 2018-06-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLSD | BUY | 2018-06-04 | 2018-06-04 | $9.07 | $100K | +11.6% | +14.9% | -26.9% |
| CLSD | SELL · 10b5-1 | 2017-10-18 | 2017-10-23 | $7.82 | $63K | -13.5% | -10.2% | -22.1% |
| CLSD | SELL | 2017-09-07 | 2017-09-11 | $7.57 | $121K | +2.0% | -4.6% | -11.8% |
| CLSD | SELL · 10b5-1 | 2017-07-19 | 2017-07-21 | $9.75 | $78K | -19.0% | -33.8% | -22.3% |
| CLSD | SELL · 10b5-1 | 2017-06-13 | 2017-06-14 | $7.89 | $63K | +23.2% | +18.6% | -4.6% |
| CLSD | SELL · 10b5-1 | 2017-05-17 | 2017-05-19 | $8.41 | $67K | -10.7% | +2.5% | -12.3% |
| CLSD | SELL · 10b5-1 | 2017-04-03 | 2017-04-05 | $7.55 | $60K | -3.0% | +3.0% | +26.3% |
| CLSD | SELL | 2016-06-07 | 2016-06-07 | $7.00 | $21 | +1.4% | -3.0% | +15.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.